A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Clinical trial NCT05726292 · RECRUITING

Trial details

NCT number: NCT05726292
Sponsor: University of Chicago
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Adenocarcinoma

Start date: 2025-01-06
Primary completion: 2027-10-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.